Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS Q0173 Fee Schedule
Last Verified: October 2026
Healthcare providers use this code to document and receive reimbursement for visits that address moderate-level medical decision-making, often including multiple diagnoses or prescription management.
Trimethobenzamide hydrochloride, 250 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
| Key Fact | Detail |
|---|---|
| Service Type | Temporary Codes Chemotherapy Anti-emetic Medications |
| Complexity Level | Low |
| Medicaid Fee Schedule | View Medicaid rates for Q0173 |
| Related NDC Codes | • 52959-0817-10 - TRIMETHOBENZAMIDE HCL 300 MG • 53489-0376-01 - TRIMETHOBENZAMIDE HCL 300 MG • 54868-5741-00 - TRIMETHOBENZAMIDE 300 MG • 55289-0953-06 - TRIMETHOBENZAMIDE 300 MG • 62135-0773-30 - TRIMETHOBENZAMIDE HCL 300 MG |
National average reimbursement for HCPCS Q0173 by major payers:
$7.29
$0.83
$0.40
$0.86
Compare published rates across providers.
Choose a payer to see a sample of rates for HCPCS Q0173.
HCPCS Q0173
5 of 25 sample ratesHigher to lower in this preview
Chu Chen
$1.76Published ratePiedmont Walton Hospital Inc
$1.26Published rateChu Chen
$0.83Published rateWildwood Sanitarium, Incorporated, Wildwood Lifestyle Center And Hospital
Wildwood Sanitarium Incorporated
$0.83Published rateJasper Health Services, Inc., Jasper Memorial Hospital
Jasper Health Services Inc
$0.83Published rate
Get a free rate benchmark for your specialty.
Choose your state and specialty to build a report from payer-published rates.
Use market rates to prepare your payer proposal.
Payer Contract Negotiation
Draft a fee schedule renegotiation letter.
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS Q0173 vs. Other Chemotherapy Anti-emetic Medications Codes
The HCPCS Q0173 code is part of the Temporary Codes services used for Chemotherapy Anti-emetic Medications. It represents a moderate-complexity encounter and is one of several codes that vary based on time spent, level of medical decision-making, and documentation requirements.
The HCPCS Q0173 code involves more provider time and moderate medical decision-making, unlike lower-level codes that require less time and simpler assessments. It typically includes multiple diagnoses, medication management, or test interpretation, leading to higher reimbursement and more detailed documentation requirements.
| Code | Complexity | Description |
|---|---|---|
| 52959-0817-10-NDC | Moderate | TRIMETHOBENZAMIDE HCL 300 MG |
| 53489-0376-01-NDC | Moderate | TRIMETHOBENZAMIDE HCL 300 MG |
| 54868-5741-00-NDC | Moderate | TRIMETHOBENZAMIDE 300 MG |
| Q0173-HCPCS | Low | Trimethobenzamide hydrochloride, 250 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS Q0173. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the Q0173 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
FREE SAMPLE MARKET COMPARISON
Let's review your payer contracts side-by-side with the market.
Bring your top codes (like HCPCS Q0173) and we'll show you how you compare in 15 minutes or less.